DSM-Firmenich AG (DSFIR) | Stock Overview & Key Data
DSM-Firmenich AG | Large-cap | Basic Materials
DSM-Firmenich AG | Large-cap | Basic Materials
DSM-Firmenich AG Performance Comparison
Stock Range
Today's Range
Low: €81.96
High: €82.80
on August 8, 2025
52 Week Range
Low: €80.82
High: €124.85
on August 4, 2025
on October 1, 2024
All-Time High: €124.85 on September 30, 2024
Explore how other NL stocks compare to their 52-week ranges: View NL Market 52-Week Insights
Key Statistics
Market Cap
€21.3B
EPS
2.72
P/E Ratio (TTM)
30.13
Forward P/E
27.04
P/B Ratio
1.01
PEG Ratio
27.04
Div. Yield
2.63%
ROE
3.52%
Beta
1.035
Debt to Equity
25.24
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
12.07%
Profit Margin
5.52%
Returns and Earnings
Return on Assets (TTM)
2.18%
Return on Equity (TTM)
3.52%
EBITDA
€561.0M
Net Income (TTM)
€718.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€50.05
Quarterly Revenue Growth (YoY)
3.40%
Quarterly Earnings Growth (YoY)
1,114.30%
Dividend Information
Last 12-Month Dividend
€2.50
Current Dividend Yield
2.63%
3-Year Average Dividend Yield
2.22%
3-Year Average Annual Dividend
€2.20
3-Year Total Dividends
€6.60
Ex-Dividend Date
May 8, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| DSM-Firmenich AG DSFIR | 21.30B Large-cap | 1.28% | -8.97% | -12.14% | -14.13% | -15.05% | -31.35% | -31.26% | -31.26% |
| Akzo Nobel N.V AKZA | 9.55B Large-cap | 3.67% | -7.62% | -2.85% | -1.72% | -1.72% | 4.17% | -20.01% | -32.89% |
| IMCD N.V IMCD | 5.72B Large-cap | 2.54% | -14.47% | -18.71% | -35.29% | -32.06% | -30.42% | -36.58% | 8.13% |
| OCI N.V OCI | 1.58B Large-cap | 1.23% | -2.77% | -1.86% | -32.97% | -33.69% | -72.07% | -79.90% | -39.51% |
| Corbion N.V CRBN | 960.42M Mid-cap | 0.61% | -11.73% | -13.44% | -26.05% | -23.94% | -21.56% | -47.82% | -52.37% |
| Avantium N.V AVTX | 127.91M Small-cap | 3.82% | -5.20% | 39.00% | -17.34% | -23.40% | -41.58% | -47.12% | -70.67% |
Ownership & Short Interest
Insider Ownership
9.64%
Institutional Ownership
30.15%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
657K
Average 90-Day Volume
508K
DSM-Firmenich AG Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in DSM-Firmenich AG would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is DSFIR's 52-week high and low?
- In the last 52 weeks, DSM-Firmenich AG reached a high of €124.85 (on October 1, 2024) and a low of €80.82 (on August 4, 2025).
- What is the market cap and P/E ratio for DSFIR?
- Curious about DSM-Firmenich AG's size and valuation? Its market capitalization stands at 21.30B. When it comes to valuation, the P/E ratio (trailing twelve months) is 30.13, and the forward P/E (looking ahead) is 27.04.
- Does DSFIR pay dividends? If so, what's the yield?
- Yes, DSM-Firmenich AG is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 2.63%, and the company has paid an average of €2.20 per share annually over the past 3 years.
- Who are DSM-Firmenich AG's main competitors or similar companies to consider before investing?
When looking at DSM-Firmenich AG, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Akzo Nobel N.V
AKZA9.55B Basic Materials Specialty Chemicals 4.17% -20.01% IMCD N.V
IMCD5.72B Basic Materials Specialty Chemicals -30.42% -36.58% OCI N.V
OCI1.58B Basic Materials Specialty Chemicals -72.07% -79.90% Corbion N.V
CRBN960.42M Basic Materials Specialty Chemicals -21.56% -47.82% Avantium N.V
AVTX127.91M Basic Materials Specialty Chemicals -41.58% -47.12% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for DSM-Firmenich AG? (e.g., ROE, Debt/Equity)
- To get a sense of DSM-Firmenich AG's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 3.52%, the Debt to Equity ratio from the most recent quarter is 25.24, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for DSFIR?
- Looking at DSM-Firmenich AG's growth, its revenue over the trailing twelve months (TTM) was €13B. Compared to the same quarter last year (YoY), quarterly revenue grew by 3.40%, and quarterly earnings saw a YoY growth of 1,114.30%.
- How much of DSFIR stock is held by insiders and institutions?
- Wondering who owns DSM-Firmenich AG stock? Company insiders (like executives and directors) hold about 9.64% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 30.15%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.